Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Novo Launches High-Dose Wegovy in the US; Evotec Pressured to List Its US Unit
Novo Nordisk has introduced a high‑dose 7.2 mg version of its obesity drug Wegovy in the United States, expanding the GLP‑1 portfolio beyond the standard 2.4 mg dose. The new formulation targets patients with severe obesity who need greater weight‑loss efficacy. Pricing is projected around $1,600 per month, aligning with Novo's premium positioning. The launch arrives as the GLP‑1 market intensifies, with rivals racing to broaden indications and dosages.
Integrations Only When Customers Demand, Not Startup Pitch
Recently more than one person called my Health Tech startup @SeamlessMD the “incumbent”. While we’ve been around 13+ years, it feels strange to call ourselves that - probably because we view the EHR as the incumbent. That said, there are...
Houston Methodist to Deploy Midstream Health’s Agentic AI Financial Action Platform Across Enterprise
Houston Methodist has partnered with Midstream Health to roll out its Agentic AI Financial Action Platform across the health system, beginning with supply‑chain operations. The AI agents ingest both structured ERP data and unstructured contract PDFs to automatically detect pricing...
Robin Weiss Obituary
Robin Weiss, a pioneering virologist who died at 86, led the 1984 discovery that CD4 is the cellular receptor for HIV and created the first UK HIV antibody test with Richard Tedder. The test enabled large‑scale, accurate detection of HIV,...
The CY 2027 Final Rule Is Out. What Changed, What's New, and Why It Matters If You Sell to Health...
CMS released the Contract Year 2027 Medicare Advantage and Part D final rule, rolling back four health‑equity requirements, removing 11 of 12 STAR measures and adding a depression‑screening metric, and inserting supplemental‑benefit provisions from the prior year’s proposal. The agency also...
How to Win Peer-to-Peer Calls: A Medical Director’s Guide
An anonymous physician medical director explains why most doctors lose peer‑to‑peer prior‑authorization calls. He reveals that utilization‑management reviewers rely on specific criteria sets—typically InterQual or MCG—and expect documented evidence that matches those checklists. The article outlines three winning tactics: ask...
Cooling Bracelet to Help Irish Women Battle Key Menopause Symptom
Irish engineer Aonghus O’Donovan has launched the MyCelsius cooling bracelet, a wrist‑worn device that drops skin temperature by 10 °C in under ten seconds. The wearable, entering the Irish market on April 7, targets menopausal hot flushes and claims an 80% efficacy...
Migraines Could Be Treated by Ramping up the Brain's Cleaning System
Researchers demonstrated that enhancing the brain's glymphatic waste‑clearance system can remove a migraine‑triggering chemical in mice, reducing facial pain symptoms. The approach repurposes a hypertension drug to boost clearance, offering a potential therapy for the one‑third of migraine sufferers who...
Sector Tariff Now More than a Threat – for some Rx Companies
Jiangsu and Shanghai Hengrui have patented selective Nav1.8 blockers that demonstrate potent pre‑clinical analgesic activity for chronic neuropathic pain. New research links chronic inflammatory signaling to early leukemic transformation in hematopoietic stem cells, suggesting anti‑inflammatory approaches could intervene before disease...
Biopharma Financings Nearly Double Vs. 2025 to $25.1B
Biopharma financing in 2026 surged to $25.1 billion, almost twice the amount raised in 2025. The jump reflects a wave of venture‑capital commitments, a robust IPO market, and heightened merger‑and‑acquisition activity. Public offerings alone added roughly $8 billion, while private rounds supplied...
STAT+: Many Cancer Patients Don’t Get Genomic Tests to Guide Treatment, Study Finds
Genomic sequencing, a key component of precision oncology, is underused in metastatic cancer care. A JAMA Network Open study of five cancer types found that only about half of patients received tumor genetic testing, with lower rates among low‑income, Medicare/Medicaid,...
Five-Drug VIPOR Regimen Shows Promise in Aggressive Blood Cancer
Researchers at Jiangsu and Shanghai Hengrui have patented selective Nav1.8 sodium‑channel blockers that alleviate pain in rodent models without cardiac or CNS effects, and plan IND‑enabling toxicology studies in 2026 with Phase I trials slated for 2027. Parallel advances in hematopoietic...
Hematopoietic Stem Cell Research Points to Leukemia’s Early Roots
Recent hematopoietic stem cell (HSC) studies reveal that chronic inflammation can seed the earliest genetic lesions that later evolve into leukemia. The research shows that inflammatory signals remodel the bone‑marrow niche, prompting mutations in primitive stem cells long before clinical...
The Imaginary of Informed Consent: Rethinking Approaches to Data Use for AI in Healthcare
The article examines how India’s Digital Personal Data Protection Act 2023 relies on informed consent to legitimize health data use for AI, but this model struggles with the complex, secondary purposes of AI training. It outlines three consent challenges: multiple...
J&J Launches Enhanced PFA Device in Europe
Johnson & Johnson received CE‑mark approval for its Varipulse Pro pulsed‑field ablation (PFA) device and is launching it across Europe. The upgraded system delivers lesions five times faster than the prior sequence while maintaining comparable efficacy and operates at a lower...
Hong Kong Doctor Axed for Posting Resuscitation Photo Faces Medical Council Case
Hong Kong’s Hospital Authority terminated Dr. Jensen So’s contract after he posted an Instagram story showing a resuscitation procedure in a public ward. The authority said the doctor breached the professional code of conduct, lacked integrity and compromised patient privacy. The...
Gilead Outlays $5bn to Acquire ADC Specialist Tubulis
Gilead announced a deal to acquire German ADC specialist Tubulis for up to $5 bn, with $3.15 bn paid upfront and up to $1.85 bn in milestones. The transaction, slated to close in Q2 2026, brings Tubulis' lead candidate TUB‑040—a NaPi2b‑directed topoisomerase‑I inhibitor in...
The Case for Mandates (Yes, Really)
In Part 1 of his two‑part series, Dr. Gator argues that vaccine mandates, despite personal objections, are an effective short‑term tool for raising immunization rates. He explains that public‑health policy targets population risk, protecting vulnerable groups such as immunocompromised children. Historical...
FDA Clears Way for IDE Pivotal Trial of the Topaz Tricuspid Valve Replacement System
The U.S. Food and Drug Administration has granted an investigational device exemption (IDE) for TRiCares' Topaz transcatheter tricuspid valve replacement system, allowing a pivotal randomized trial across the United States, Canada, and Europe. The study will involve up to 75...
Wash. FD Becomes Test for University's Pre-Med Expansion
The University of Washington expanded its Health Care Alternative Spring Break program to include pre‑med students shadowing emergency medical services at Longview Fire Department. In 2024, 82% of the department’s calls were medical, underscoring the relevance of pre‑hospital experience. Students...
Virtual Twins Guide Nearly 2,000 Surgeries and Growing
Nearly 2,000 procedures have been guided by virtual-twin modeling, where a dynamic digital replica is used for practice surgery, and it keeps getting better. https://spectrum.ieee.org/living-heart-project-virtual-twins
Accelerating Early-Onset Cancer Cause Research for Prevention
Accelerating discovery of cancer causes for prevention in the era of rising early-onset cancers 🌟This roadmap aims to stimulate advances to accelerate cancer etiology research and prevention in the era of rising early-onset cancers. https://t.co/d0z6EHDpTh https://t.co/H6I76e4tFB
These Healthcare Stocks Offer Value and Rapid Profit Growth
Healthcare stocks are gaining momentum as the Centers for Medicare & Medicaid Services signaled higher Medicare Advantage payment rates for 2027. The prospect of increased reimbursements is boosting profit outlooks for managed‑care providers, with CVS Health rallying 4.5% after the...
Shift Focus: Prioritize Cancer Prevention Over Detection
We should be prioritizing prevention of cancer instead of the major focus on detection and treatment. A new @CellCellPress perspective https://t.co/Gkso3gGPOI
Peptide Vials Contaminated, Underdosed, and Unsafe
Besides the lack of data for safety or efficacy on peptides, or any assurance of sterility, here's what an independent lab found of samples: —The vial of BPC-157 contained lead —The vial of TB-500 contained endotoxins —The vial of CJC-1295 contained <42% of...
Stop Waiting to Be Asked: What Operators Really Need From Their Revenue Cycle Partners
The article argues that healthcare revenue‑cycle partners must shift from reactive "tell us what you need" approaches to proactive, anticipatory support. Operators juggling access, staffing, patient experience, and finances often lack the bandwidth to articulate needs during crises. By identifying...
How U.S. Healthcare Costs Soar Without Better Outcomes
The multitude of ways that jack up American healthcare costs (without improving outcomes) @armollica @WSJGraphics @annawmathews gift link https://t.co/FjseZsYQiT https://t.co/QcAmpv2L5r
HexemBio Raises $10.4M Seed for Stem Cell Rejuvenation
HexemBio announced a $10.4 million seed round, led by Draper Associates with participation from SOSV, Seraphim and other investors. The biotech is developing a Synthetic Human Yolk Sac that temporarily houses a patient’s blood stem cells to rejuvenate their function before...
Insurers Committed to Cutting Prior Authorizations Have Eliminated 11% so Far
Major insurers have trimmed 11% of prior authorizations, eliminating roughly 6.5 million requests for U.S. patients, according to AHIP and the Blue Cross Blue Shield Association. The reduction is most pronounced in Medicare Advantage, where cuts exceed 15%. Insurers also report...
Wegovy HD Now Available in the U.S.
Novo Nordisk launched Wegovy HD, a 7.2 mg semaglutide injection, across the United States. Clinical data from the Phase III Step Up trial showed an average 21% weight loss under ideal conditions and 19% in real‑world adherence, with nearly one‑third achieving ≥25% loss....
A Common Antidepressant Shows Promise in Treating Methamphetamine Dependence
A new JAMA Psychiatry study shows the antidepressant mirtazapine can modestly reduce methamphetamine use. In the double‑blind Tina Trial, 339 Australian participants received either 30 mg daily mirtazapine or placebo for 12 weeks. Those on mirtazapine cut meth use by an...
TNO155
TNO155, also known as batoprotafib, is an oral, allosteric SHP2 inhibitor that stabilizes the phosphatase in its inactive conformation. Developed by Novartis in Cambridge, MA, it emerged from a 1.5 million‑compound high‑throughput screen combined with structure‑based drug design, becoming the first...
PharmaForce Appoints Industry Leader Lynn Eschenbacher to Lead Next Phase of 340B Strategy and Execution
PharmaForce has named Lynn Eschenbacher, PharmD, MBA, FASHP, as its new Chief Pharmacy and Strategy Officer to steer the company’s 340B program strategy. Eschenbacher brings over 25 years of pharmacy leadership across major health systems, most recently at Quva Pharma. The...
AI Docs Integrated Into EHR Let Doctors Focus on Care
No one becomes a doctor to click boxes on a drop-down menu. By bringing AI-powered documentation directly into Southwest General Health Center’s EHR, we’re turning conversations into structured notes and helping clinicians focus on patient care. https://t.co/1hep681ixQ
How Tech-Enabled Independent Pharmacies Can Address America’s Medication Adherence Crisis
Medication non‑adherence still costs U.S. drug makers roughly $250 billion a year, despite billions spent on marketing. Independent pharmacies, which patients visit nearly twice as often as primary‑care doctors, are emerging as a critical touchpoint as chain stores close. New pharmacy‑focused...
The Price Americans Pay for Medicine Has Gotten Horribly Out of Control. Here’s How to Fix It.
Humira, AbbVie’s adalimumab used by over 300,000 Americans, continues to dominate the market even after its patent expired, keeping prices sky‑high. The drug’s outsized share illustrates systemic flaws in U.S. pharmaceutical distribution, where limited biosimilar competition and opaque pricing inflate...
Ambulances Diverted After Cyberattack Hits Mass. Hospital
Brockton Hospital in Massachusetts is diverting ambulances and cancelling certain services after a cybersecurity incident disrupted its information systems. Chemotherapy infusions and retail pharmacies were suspended, while inpatient and walk‑in emergency care remain operational. The hospital reverted to paper records...
Maven Clinic Partners with Wellthy to Offer Integrated Family Care Benefits for Employers
Maven Clinic has teamed up with caregiving platform Wellthy to deliver an integrated family‑care benefit for employers. The joint solution merges Maven’s virtual women’s and family health services with Wellthy’s care‑coordination and backup‑care logistics, targeting the “sandwich generation” of workers...
STAT+: Pharmalittle: We’re Reading About FDA Backing Domestic Production, Another Gilead Deal, and More
The FDA, leveraging the Trump administration’s budget, unveiled proposals to boost domestic drug development and manufacturing, including streamlined early‑stage trials and a rule letting U.S. generic makers challenge brand patents a month before foreign competitors. Commissioner Marty Makary framed the...
Safer Together Plan Prioritizes Nurses' Physical and Mental Health
The Safer Together National Action Plan includes protecting #nurses + healthcare workers physically + mentally, it may hold it all together. 🎧 Episode 132: Safer Together | The #Nurse Well‑Being Imperative Apple: https://t.co/6yY7RbqjRc Spotify: https://t.co/j3wvzMNTbL @ANANursingWorld @TheIHI
Lest We "Off" Ourselves (Cautionary Examples)
Investigative videos reveal that wellness influencers Mark Hyman and Jordan Peterson suffered severe sepsis after undergoing experimental stem‑cell and regenerative‑medicine procedures at Dr. Adil Khan’s unregulated clinics. The series links spinal injections and intravenous therapies to bacterial infections, highlighting the...
Key Biosimilars Events of March 2026
March 2026 saw a surge of biosimilar activity, highlighted by Celltrion’s launch of Remsima IV in the EU and Avtozma SC in the United States, expanding both IV and sub‑cutaneous options for infliximab and tocilizumab. Samsung Bioepis inked a global...
Oxytocin Reverses Isolation‑induced Neuropsychiatric Deficits via Brain, Immune, Microbiome
Oxytocin attenuates isolation-evoked emotional and social behavioral dysregulation through neural, immune, and microbiota mechanisms "Our study confirms the therapeutic effects of OXT in reversing isolation-induced neuropsychiatric disorders and elucidates its potential regulatory mechanisms, offering important implications for clinical interventions." https://t.co/hXkWRD1gMV
FDA-Approved Drug Manufacturing Deals Shift to Europe
In 2025, U.S. contract manufacturing deals for FDA‑approved drugs fell sharply, while Europe recorded more than three times the U.S. volume. Despite a 15% U.S. tariff on EU pharmaceuticals, major U.S. firms such as Johnson & Johnson and Vertex invested...
SNY's Atopic Dermatitis Candidate Fails; NKTR Rem
$SNY next-gen atopic dermatitis drug failed in P2b. Missed primary endpoint. MOA was IL13xTSLP. Now what have they got to follow up dupi if (when?) they discontinue amlitelimab? $NKTR 👀 🤷🏻♂️ Remains the only new MoA...
Devex CheckUp: Trump Asks to Eliminate Billions for Global Health — Again
The White House’s FY 2027 budget request allocates $5.1 billion to global health, a modest increase over the previous year but far below the $9.4 billion Congress approved for FY 2026. The proposal cuts funding for the World Health Organization, the Pan‑American Health Organization,...
Daily Multivitamin Cuts Biological Aging by Four Months, Study Finds
Researchers from Mass General Brigham reported that taking a daily multivitamin slowed biological aging by roughly four months in adults aged 60 and older. The finding, published in Nature Medicine, could reshape how clinicians and consumers view over‑the‑counter supplements.
Samsung Introduces Android Enterprise and Knox Manage to Galaxy XR for Healthcare Deployments
Samsung upgraded its Galaxy XR headset with Android Enterprise support and Samsung Knox Manage integration, aiming at healthcare deployments. The enhancements let hospital IT departments manage the headsets like smartphones, applying data policies, network configurations, and remote lock or wipe functions....
Women in Northern Ireland Welcome Introduction of Miscarriage Leave
Northern Ireland has passed legislation granting statutory miscarriage leave, allowing employees up to five days of paid time off after a miscarriage. The measure aligns the region with England and Wales, which introduced similar provisions last year. Employers will treat...
Women’s Health Is Central to the Future of Digital Health
Digital health tools have long suffered from gender bias because training data and clinical trials underrepresent women. The Consumer Technology Association (CTA) has introduced the first ANSI‑accredited women’s health standard, giving developers a concrete framework for inclusive design, testing, and...